Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome
<p dir="ltr">In a cohort of patients with differing severity of COVID-19 disease, including non-survivors, plasma proteomic analysis identified biomarkers of COVID-19 disease progression [1]. The top pathways identified by Shu et al. were those of platelet degranulation and the compl...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , |
| Published: |
2021
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|